Tags

Type your tag names separated by a space and hit enter

Acceptability of injectable contraceptives in Assiut, Egypt.
Contraception. 1988 Dec; 38(6):697-710.C

Abstract

The present work was a randomized comparative study of two injectable progestogen-only contraceptives. The first group (200 subjects) received 150 mg of depotmedroxyprogesterone acetate (Depoprovera) every 84 +/- 7 days and the second (200 subjects) received 200 mg of norethisterone enanthate (Noristerat) every 56 +/- 7 days. Acceptors of injectable contraceptives in Assiut, Egypt, were mainly women looking for fertility termination. Menstrual disruption was the main side effect among both treatment groups. Amenorrhoea was the commonest menstrual complaint and was the main reason for discontinuation in both groups. Only one pregnancy occurred during NET-EN use; two more pregnancies occurred, one in each of the two groups but there were indications that conception preceded the first injection. Menstrual irregularities were generally more frequent with DMPA users. However, DMPA had better one-year continuation rates than NET-EN (68.8 +/- 3.5 and 57.1 +/- 3.6 per 100 women, respectively).

Authors+Show Affiliations

Department of Obstetrics and Gynaecology Assiut, Egypt.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

2975583

Citation

Salem, H T., et al. "Acceptability of Injectable Contraceptives in Assiut, Egypt." Contraception, vol. 38, no. 6, 1988, pp. 697-710.
Salem HT, Salah M, Aly MY, et al. Acceptability of injectable contraceptives in Assiut, Egypt. Contraception. 1988;38(6):697-710.
Salem, H. T., Salah, M., Aly, M. Y., Thabet, A. I., Shaaban, M. M., & Fathalla, M. F. (1988). Acceptability of injectable contraceptives in Assiut, Egypt. Contraception, 38(6), 697-710.
Salem HT, et al. Acceptability of Injectable Contraceptives in Assiut, Egypt. Contraception. 1988;38(6):697-710. PubMed PMID: 2975583.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acceptability of injectable contraceptives in Assiut, Egypt. AU - Salem,H T, AU - Salah,M, AU - Aly,M Y, AU - Thabet,A I, AU - Shaaban,M M, AU - Fathalla,M F, PY - 1988/12/1/pubmed PY - 1988/12/1/medline PY - 1988/12/1/entrez KW - Africa KW - Amenorrhea KW - Arab Countries KW - Biology KW - Comparative Studies KW - Contraception KW - Contraception Continuation KW - Contraceptive Agents KW - Contraceptive Agents, Female KW - Contraceptive Agents, Progestin--administraction and dosage KW - Contraceptive Agents, Progestin--side effects KW - Contraceptive Agents--administraction and dosage KW - Contraceptive Agents--side effects KW - Contraceptive Methods--administraction and dosage KW - Contraceptive Usage KW - Demographic Factors KW - Developing Countries KW - Diseases KW - Egypt KW - Endocrine System KW - Family Planning KW - Fertility KW - Fertility Measurements KW - Genital Effects, Female KW - Genitalia KW - Genitalia, Female KW - Hormones KW - Incidence KW - Injectables--administraction and dosage KW - Measurement KW - Mediterranean Countries KW - Medroxyprogesterone Acetate--administraction and dosage KW - Medroxyprogesterone Acetate--side effects KW - Menstruation Disorders KW - Norethindrone Enanthate--administraction and dosage KW - Norethindrone--administraction and dosage KW - Northern Africa KW - Physiology KW - Population KW - Population Dynamics KW - Pregnancy Rate KW - Reproductive Control Agents KW - Research Methodology KW - Studies KW - Urogenital Effects KW - Urogenital System SP - 697 EP - 710 JF - Contraception JO - Contraception VL - 38 IS - 6 N2 - The present work was a randomized comparative study of two injectable progestogen-only contraceptives. The first group (200 subjects) received 150 mg of depotmedroxyprogesterone acetate (Depoprovera) every 84 +/- 7 days and the second (200 subjects) received 200 mg of norethisterone enanthate (Noristerat) every 56 +/- 7 days. Acceptors of injectable contraceptives in Assiut, Egypt, were mainly women looking for fertility termination. Menstrual disruption was the main side effect among both treatment groups. Amenorrhoea was the commonest menstrual complaint and was the main reason for discontinuation in both groups. Only one pregnancy occurred during NET-EN use; two more pregnancies occurred, one in each of the two groups but there were indications that conception preceded the first injection. Menstrual irregularities were generally more frequent with DMPA users. However, DMPA had better one-year continuation rates than NET-EN (68.8 +/- 3.5 and 57.1 +/- 3.6 per 100 women, respectively). SN - 0010-7824 UR - https://www.unboundmedicine.com/medline/citation/2975583/Acceptability_of_injectable_contraceptives_in_Assiut_Egypt_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0010-7824(88)90051-0 DB - PRIME DP - Unbound Medicine ER -